Form 4: Puma Biotechnology Director Receives Equity Grant

Director Michael Patrick Miller was granted 27,000 restricted stock units in Puma Biotechnology, Inc.

Summary

• Director Michael Patrick Miller acquired 27,000 restricted stock units (RSUs) of Puma Biotechnology, Inc. (PBYI) common stock.
• The transaction occurred on June 11, 2026.
• The RSUs were granted at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership increased to 81,000 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• The grant aligns the director's interests with those of shareholders through increased equity ownership.

Negatives

• None identified.

Risks

• Vesting of the restricted stock units is contingent upon the director's continued service with the issuer.

Future Outlook

The restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual shareholder meeting, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term oversight and alignment with shareholder value in the biotechnology sector.

Comparison to Industry Standards

• The grant of restricted stock units as part of director compensation is consistent with standard practices for mid-cap biotechnology firms.
• The vesting schedule tied to annual meetings or one-year anniversaries is a common retention mechanism in the industry.

Stakeholder Impact

• Shareholders may view the increased equity stake as a positive sign of director commitment to the company's long-term performance.

Next Steps

• Vesting of the 27,000 RSUs on the earlier of the one-year anniversary or the next annual shareholder meeting.

Key Dates

Keywords

Puma Biotechnology, PBYI, Form 4, Insider Trading, Equity Grant, Director Compensation